As another example, in line with our primary analysis, higher GFAP concentrations were associated with an increased risk of death after symptom onset in participants with bvFTD and the combined group of all FTD syndromes (HR = 2.11, p = 6.0E-08 and HR = 1.40, p = 1.2E-06, respectively). This evidence concerns the gene GFAP and behavioral variant of frontotemporal dementia.